Novartis Investigative Site

Sint-Truiden 3800

0 studies enrolling now · 2 studies all time

What they study most

Primary Progressive Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. — Stopped early